Quadrivalent Global Market Report 2025

Description

A quadrivalent vaccine stimulates the immune system to respond to distinct antigens, typically targeting four different viruses or bacteria. In the context of influenza, a quadrivalent vaccine is designed to provide protection against four specific flu viruses, including two type A and two type B viruses.

The primary types of quadrivalent vaccines include intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot involves injecting the vaccine between the epidermis and hypodermis, the top and bottom layers of the skin, as defined by the Center for Disease Control (CDC). These vaccines are formulated using various technologies, including conjugated, live, inactivated, recombinant, toxoid, and others, aiming to immunize against a range of diseases such as cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and others affecting both pediatric and adult age groups. Distribution channels for these vaccines include hospitals, pharmacies, government suppliers, and other outlets.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quadrivalent market size has grown strongly in recent years. It will grow from $8.87 billion in 2024 to $9.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to disease complexity, educational initiatives, past health events, healthcare growth, technological progress.

The quadrivalent market size is expected to see rapid growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to global health events, competitive dynamics, educational campaigns, regulatory changes, evolving disease patterns. Major trends in the forecast period include disease prevalence, regulatory environment, healthcare infrastructure, consumer awareness and education, competitive landscape.

The increasing prevalence of chronic and infectious diseases is anticipated to drive the growth of the quadrivalent market in the future. A chronic disease is a long-term condition resulting from genetics and lifestyle, while an infectious disease is any illness caused by an infectious agent such as a virus, bacteria, fungus, or protozoan. Quadrivalent vaccines play a crucial role in preventing morbidity and mortality from serious infections, as well as addressing diseases beyond the specific infections they are designed to combat. These vaccines are also utilized to prevent chronic (non-communicable) diseases when infectious agents contribute to carcinogenesis. For instance, in September 2024, a report from the Centers for Disease Control and Prevention, a non-profit organization based in the U.S., indicated that in Week 37, 0.5% of specimens tested positive for influenza, with 91.4% being influenza A and 8.6% influenza B. Cumulatively, since October 1, 2023 (Week 40), 8.7% of specimens tested positive, with 69.2% being influenza A and 30.8% influenza B, reflecting a higher overall positivity rate and an increasing proportion of influenza B cases over time. Therefore, the rising prevalence of chronic and infectious diseases is driving the growth of the quadrivalent market.

The expected growth in the quadrivalent market is also fueled by the global expansion of immunization coverage. Immunization coverage, indicating the proportion of a population receiving specific vaccines within a defined period, drives increased demand for vaccines. Quadrivalent vaccines, protecting against four strains, are often integrated into routine vaccination programs to combat multiple disease threats in a single shot. The World Health Organization reported an improvement in the number of zero-dose children, decreasing from 18.1 million in 2021 to 14.3 million in 2022. Moreover, global coverage for the initial dose of the human papillomavirus (HPV) vaccine in girls increased from 16% in 2021 to 21% in 2022. Thus, the rising global immunization coverage is expected to propel the quadrivalent market forward.

A key trend gaining prominence in the quadrivalent market is product innovation. Major companies in the sector are actively developing innovative solutions to reinforce their market positions. AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. This FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49 is administered through a needle-free nasal spray. It is available in trivalent or quadrivalent formulations, providing a live attenuated influenza vaccine (LAIV) covered by most health insurance plans and the vaccines for children program.

Major companies operating in the quadrivalent market are prioritizing safer and innovative vaccine delivery technologies, such as nanoparticle technology, to boost their revenues. This nanoparticle technology mimics the virus's outer structure using virus-like particles (VLPs) without containing any live genetic material, which enhances both safety and immune response. For example, in March 2024, Cadila Pharmaceuticals, a pharmaceutical company based in India, launched its advanced Quadrivalent Influenza Vaccine, designed to provide protection against four distinct strains of the influenza virus, including two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation improves the vaccine's efficacy by targeting a broader range of circulating influenza viruses, making it particularly effective during flu seasons. The aQIV aims to stimulate a strong immune response, thereby reducing the incidence of influenza-related morbidity and mortality. Its development highlights ongoing efforts to enhance public health outcomes in response to evolving viral strains.

In February 2023, China-based biotechnology company Clover Biopharmaceuticals Ltd. entered into a partnership with Adimmune Corporation, a Taiwan-based biopharmaceutical company. This collaboration leverages Adimmune's manufacturing and distribution expertise in providing essential vaccines to Asian populations. Clover aims to strengthen its position as a premier respiratory vaccine franchise and enhance synergies with ongoing COVID-19 vaccine commercialization. As part of this collaboration, Clover will distribute Adimmune's AdimFlu-S (QIS), the only imported quadrivalent influenza vaccination authorized in mainland China, utilizing its established commercial infrastructure.

Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quadrivalent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The quadrivalent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray
2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies
3) By Disease: Cancer; Hepatitis; Pneumococcal Disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases
4) By Age Group: Pediatric; Adult
5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)
Subsegments:
1) By Intradermal Shot: Standard Intradermal Injection; Needle-Free Intradermal Delivery
2) By Intramuscular Injection: Standard Intramuscular Injection; Adjuvanted Intramuscular Injection
3) By Nasal Spray: Live Attenuated Nasal Spray; Inactivated Nasal Spray
Companies Mentioned: AstraZeneca Plc; Serum Institute of India Private Limited; Sanofi S.A.; GlaxoSmithKline Plc; CSL Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23690

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Quadrivalent Growth Analysis And Strategic Analysis Framework

5.1. Global Quadrivalent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Quadrivalent Market Growth Rate Analysis
5.4. Global Quadrivalent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Quadrivalent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Quadrivalent Total Addressable Market (TAM)

6. Quadrivalent Market Segmentation

6.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intradermal Shot
Intramuscular Injection
Nasal Spray
6.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conjugated
Live
Inactivated
Recombinant
Toxoid
Other Technologies
6.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Hepatitis
Pneumococcal Disease
COVID-19
Influenza
Human Papilloma Virus
Meningococcal Disease
Polio
Rotavirus
Other Diseases
6.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
6.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital And Pharmacy
Government Suppliers
Other Channels (NGOs)
6.6. Global Quadrivalent Market, Sub-Segmentation Of Intradermal Shot, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Intradermal Injection
Needle-Free Intradermal Delivery
6.7. Global Quadrivalent Market, Sub-Segmentation Of Intramuscular Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Intramuscular Injection
Adjuvanted Intramuscular Injection
6.8. Global Quadrivalent Market, Sub-Segmentation Of Nasal Spray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Nasal Spray
Inactivated Nasal Spray

7. Quadrivalent Market Regional And Country Analysis

7.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quadrivalent Market

8.1. Asia-Pacific Quadrivalent Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quadrivalent Market

9.1. China Quadrivalent Market Overview
9.2. China Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quadrivalent Market

10.1. India Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quadrivalent Market

11.1. Japan Quadrivalent Market Overview
11.2. Japan Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quadrivalent Market

12.1. Australia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quadrivalent Market

13.1. Indonesia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quadrivalent Market

14.1. South Korea Quadrivalent Market Overview
14.2. South Korea Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quadrivalent Market

15.1. Western Europe Quadrivalent Market Overview
15.2. Western Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quadrivalent Market

16.1. UK Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quadrivalent Market

17.1. Germany Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quadrivalent Market

18.1. France Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quadrivalent Market

19.1. Italy Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quadrivalent Market

20.1. Spain Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quadrivalent Market

21.1. Eastern Europe Quadrivalent Market Overview
21.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quadrivalent Market

22.1. Russia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quadrivalent Market

23.1. North America Quadrivalent Market Overview
23.2. North America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quadrivalent Market

24.1. USA Quadrivalent Market Overview
24.2. USA Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quadrivalent Market

25.1. Canada Quadrivalent Market Overview
25.2. Canada Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quadrivalent Market

26.1. South America Quadrivalent Market Overview
26.2. South America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quadrivalent Market

27.1. Brazil Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quadrivalent Market

28.1. Middle East Quadrivalent Market Overview
28.2. Middle East Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quadrivalent Market

29.1. Africa Quadrivalent Market Overview
29.2. Africa Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quadrivalent Market Competitive Landscape And Company Profiles

30.1. Quadrivalent Market Competitive Landscape
30.2. Quadrivalent Market Company Profiles
- 30.2.1. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Quadrivalent Market Other Major And Innovative Companies

31.1. Bharat Biotech International Limited
31.2. Hualan Biological Engineering Inc.
31.3. Merck & Co. Inc.
31.4. Johnson & Johnson Services Inc.
31.5. Pfizer Inc.
31.6. Bio Med Pvt. Ltd.
31.7. Walvax Biotechnology Co. Ltd.
31.8. Chongqing Zhifei Biological Products Co. Ltd.
31.9. Emergent BioSolutions Inc.
31.10. Biological E. Limited
31.11. GSK Biologicals SA
31.12. Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences
31.13. Wuhan Institute of Biological Products Co. Ltd.
31.14. Beijing Tian Tan Biological Products Co. Ltd.
31.15. Shanghai Zhijiang Bio-pharm Co. Ltd.

32. Global Quadrivalent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quadrivalent Market

34. Recent Developments In The Quadrivalent Market

35. Quadrivalent Market High Potential Countries, Segments and Strategies

35.1 Quadrivalent Market In 2029 - Countries Offering Most New Opportunities
35.2 Quadrivalent Market In 2029 - Segments Offering Most New Opportunities
35.3 Quadrivalent Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer